Log in
Enquire now
‌

US Patent 7919621 Tricyclic inhibitors of 5-lipoxygenase

Patent 7919621 was granted and assigned to Amira Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Amira Pharmaceuticals
Amira Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
79196210
Patent Inventor Names
Bowei Wang0
Thomas Jonathan Seiders0
John Howard Hutchinson0
Brian Andrew Stearns0
Date of Patent
April 5, 2011
0
Patent Application Number
116262220
Date Filed
January 23, 2007
0
Patent Primary Examiner
‌
Rita J Desai
0
Patent abstract

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7919621 Tricyclic inhibitors of 5-lipoxygenase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.